SCHEMBL7695863

SCHEMBL7695863

CC(C)CCCC[C@@H](N)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.48
TRPA1 O75762 1/20 0.48
LMNA P02545 2/20 0.48
SPHK1 Q9NYA1 2/20 0.41
OPRM1 P35372 1/20 0.38
LTA4H P09960 1/20 0.35
TP53 P04637 2/20 0.34
BLM P54132 2/20 0.34
CYP2D6 P10635 2/20 0.33
GMNN O75496 1/20 0.33
POLB P06746 1/20 0.33
THPO P40225 1/20 0.33
MTOR P42345 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
CETP P11597 1/20 0.33
HTT P42858 1/20 0.33
UBE2N P61088 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6570850 0.97 TRPV1 (0.52) TRPV1TRPA1LMNASPHK1OPRM1
SCHEMBL6696129 0.97 TRPV1 (0.52) TRPV1TRPA1LMNASPHK1OPRM1
SCHEMBL6698430 0.97 TRPV1 (0.52) TRPV1TRPA1LMNASPHK1OPRM1
SCHEMBL6682836 0.94
SCHEMBL18571463 0.84 TRPV1 (0.45) TRPV1TRPA1LMNASPHK1OPRM1
SCHEMBL1779196 0.81
SCHEMBL13374800 0.81
SCHEMBL16306530 0.81
SCHEMBL10798330 0.81 TRPV1 (0.50) TRPV1TRPA1LMNASPHK1OPRM1
SCHEMBL23623625 0.80 TRPV1 (0.52) TRPV1TRPA1LMNASPHK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160338969-A1 BIOCOMPATIBLE POLYACRYLATE COMPOSITIONS AND METHODS OF USE UNIVERSITY OF SOUTH FLORIDA (US) 2016-11-24 US disclosed
US-6403587-B1 AUTOIMMUNE DISEASES, ACUTE AND CHRONIC INFLAMMATORY CONDITIONS, ALLERGIC CONDITIONS, INFECTION ASSOCIATED WITH INFLAMMATION, VIRAL, TRANSPLANTATION TISSUE REJECTION, ATHEROSCLEROSIS, RESTENOSIS, HIV INFECTIVITY, AND PFIZER INC. 2002-06-11 US disclosed